Multistate Assessment of SARS-CoV-2 Seroprevalence in Blood Donors

CDC is conducting a nationwide COVID-19 seroprevalence survey in 25 U.S. metropolitan areas to understand the percentage of people in the United States who may have been infected with SARS-CoV-2, the virus that causes COVID-19.